Chinese General Practice ›› 2023, Vol. 26 ›› Issue (03): 268-273.DOI: 10.12114/j.issn.1007-9572.2022.0621
Special Issue: 呼吸疾病文章合辑; 述评栏目最新文章合辑
• Editorial • Previous Articles Next Articles
Received:
2022-08-11
Revised:
2022-10-15
Published:
2023-01-20
Online:
2022-11-04
Contact:
NING Kang
About author:
通讯作者:
宁康
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0621
项目 | Early COPDa | COPD in young people | pre-COPD | Mild COPD |
---|---|---|---|---|
吸烟史 | 存在 | 存在 | 无要求 | 存在 |
症状 | 无要求 | 无要求 | 慢性咳嗽咳痰 | mMRC评分0~1分,CAT评分<10分 |
FEV1/FVC | <LLN | <0.7 | >0.7 | <0.7 |
FEV1下降速率 | >60 ml/年 | 无要求 | 存在异质性 | 无要求 |
FEV1%pred | 无要求 | <80% | >80% | >80% |
年龄 | <50岁 | 20~50岁 | 任何年龄 | 任何年龄 |
影像学表现 | 肺气肿,空气滞留或支气管增厚 | 可能存在肺气肿 | 有或没有肺气肿 | N/A |
Table 1 Criteria for early detection of COPD
项目 | Early COPDa | COPD in young people | pre-COPD | Mild COPD |
---|---|---|---|---|
吸烟史 | 存在 | 存在 | 无要求 | 存在 |
症状 | 无要求 | 无要求 | 慢性咳嗽咳痰 | mMRC评分0~1分,CAT评分<10分 |
FEV1/FVC | <LLN | <0.7 | >0.7 | <0.7 |
FEV1下降速率 | >60 ml/年 | 无要求 | 存在异质性 | 无要求 |
FEV1%pred | 无要求 | <80% | >80% | >80% |
年龄 | <50岁 | 20~50岁 | 任何年龄 | 任何年龄 |
影像学表现 | 肺气肿,空气滞留或支气管增厚 | 可能存在肺气肿 | 有或没有肺气肿 | N/A |
[1] |
|
[2] |
|
[3] |
Global strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease 2022 report[EB/OL].(2021-11-15)[2022-04-18].
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
樊静,丛舒,王宁,等. 2014-2015年中国40岁及以上慢性阻塞性肺疾病患者戒烟状况[J]. 中华流行病学杂志,2020,41(7):1021-1027. DOI:10.3760/cma.j.cn112338-20200124-00057.
|
[37] |
|
[38] |
|
[39] |
|
[40] |
|
[41] |
|
[42] |
|
[43] |
|
[44] |
张小娥,张彩莲. 慢性阻塞性肺疾病流行病学及疾病经济负担研究进展[J]. 中国慢性病预防与控制,2017,25(6):472-476. DOI:10.16386/j.cjpccd.issn.1004-6194.2017.06.021.
|
[45] |
|
[46] |
|
[47] |
|
[48] |
邱晨,王凤燕,陈荣昌. 推进健康中国慢性呼吸系统疾病防治行动计划的实施[J]. 中华医学杂志,2019,99(48):3761-3764. DOI:10.3760/cma.j.issn.0376-2491.2019.48.001.
|
[1] | LI Hao, LI Peijin, LIU Tingting, CUI Yiyuan, LI Sicong, LIU Lixing, FENG Li, Working Group on Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment Guidelines for Cancer Pain. Guidelines on the Diagnosis and Treatment of Cancer Pain by Integrated Traditional Chinese and Western Medicine [J]. Chinese General Practice, 2025, 28(30): 3729-3740. |
[2] | TIAN Chen, LIU Jianing, TIAN Jinhui, GE Long. Living Systematic Reviews: Methods and Processes for Development [J]. Chinese General Practice, 2025, 28(30): 3853-3860. |
[3] | WANG Tingting, TANG Yong, ZHANG Wenke, LI Zhigang. Research Progress on Exercise Intervention of Hyperuricemia [J]. Chinese General Practice, 2025, 28(30): 3841-3846. |
[4] | ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping. Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(27): 3466-3472. |
[5] | HUANG Yulin, WANG Haoyun, LI Yanmei, XIAO Xueying. Symptom Clusters in Gastric Cancer Patients Receiving Chemotherapy: a Scoping Review [J]. Chinese General Practice, 2025, 28(26): 3338-3344. |
[6] | ZHI Congcong, LI Xue, CHENG Yicheng, WANG Xiaolong, ZHENG Lihua. Guidelines for Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Hemorrhoids (2025 Edition) [J]. Chinese General Practice, 2025, 28(26): 3217-3228. |
[7] | TANG Shangfeng, HUANG Yangzhen, ZHENG Yanxi, PAN Yangyang, XIONG Zhongbao, QING Hua, SONG Jia, WEI Yilin, DONG Heng, WANG Chunying, CHEN Manwei, ZHANG Kangkang. Specification for the Integration of Healthcare and Prevention Services in Diabetes at the Primary Level [J]. Chinese General Practice, 2025, 28(25): 3096-3103. |
[8] | TANG Shangfeng, HUANG Yangzhen, PAN Yangyang, ZHENG Yanxi, XIONG Zhongbao, ZHANG Kangkang, SONG Jia, WEI Yilin, WANG Chunying, DONG Heng, CHEN Manwei, QING Hua. Specification for the Integration of Healthcare and Prevention Services in Hypertension at the Primary Level [J]. Chinese General Practice, 2025, 28(25): 3089-3095. |
[9] | PAN Qi, REN Jingjing, MA Fanghui, HU Mengjie. Survey of General Practitioners' Cognition and Needs for AI Assisted Diagnosis and Treatment Systems [J]. Chinese General Practice, 2025, 28(25): 3127-3136. |
[10] | LI Miaoxiu, ZHU Bowen, KONG Lingjun, FANG Min. Progress in Research on Clinical Assessment Tools for Conservative Treatment of Adolescent Idiopathic Scoliosis [J]. Chinese General Practice, 2025, 28(24): 3079-3088. |
[11] | LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078. |
[12] | XIAO Yao, WAN Jun. Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants [J]. Chinese General Practice, 2025, 28(24): 3066-3071. |
[13] | ZHOU Lianpeng, LI Weifeng, DONG Xingang, WANG Xiaoyuan. Research Progress on the Role of Copper Homeostasis Regulation Mechanism in Cognition Disorder [J]. Chinese General Practice, 2025, 28(23): 2941-2949. |
[14] | RUAN Wanbai, LI Junfeng, YIN Yanmei, PENG Lei, ZHU Kexiang. Research Progress of Targeted Therapy and Immunotherapy for Pancreatic Cancer [J]. Chinese General Practice, 2025, 28(23): 2950-2960. |
[15] | YANG Ji, ZHANG Yao, ZHAO Yingqiang, ZHANG Qiuyue. Evaluation of the Effectiveness of TCM Three-level Prevention and Control Model in the Management of Patients with Coronary Heart Disease and Stroke: a Single-center, Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(22): 2750-2761. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||